Exploratory studies on beneficiation of low-grade Banded Iron ore Formations (BIF) of Karnataka, India

Iron ore is the basic raw material for production of metallic iron. With depletion of high-grade resources and fine dissemination of valuable minerals in the abundantly available low-grade banded iron ore formations (BIF), liberation is achieved at finer sizes. Hence, it necessitated all beneficiation techniques to be operated at this finer size. However, physical separation techniques have limitations in separation efficiency. A combination of pre-concentration technique such as magnetic separation followed by flotation of magnetic fraction proved to be promising in achieving the respectable grade. A low-grade iron ore sample (BIF) of Karnataka, India was subjected to high intensity magnetic separation followed by flotation for enhancing its grade and recovery. Laboratory scale studies on this ore assaying 39.80 Fe%, 39.62 SiO2% and 1.73 Al2O3% indicated that it could be improved to 63.78 Fe%, 3.10 SiO2% and 1.01 Al2O3% at an overall iron recovery of 24% only. However, attempts are being made to further improve the iron recovery

Flotation of low-grade graphite ore using collector derived from low density polyethylene waste

The increasing wide range of applications of graphite for electrode, lubricants, refractory applications especially the recent surging electric automobile industry, resulting in significant need of graphite in future. Graphite demand in the energy storage industry is expected to grow 15 times faster than today's demand by 2030. Due to depleting high-grade ore, utilization of low-grade ore by beneficiation becomes utmost importance for sustainable development and resource management. In this work, low-grade graphite ore from Tamil Nadu, India with 86.84% ash was beneficiated by flotation technique for recovering graphite with lower ash content. Flotation, a surface phenomena, based on the surface hydrophobicity of the mineral surface to be separated and since graphite is naturally flotation mineral, this technique is adopted for beneficiation. The mostly commonly used collector in graphite flotation is diesel. In view of continuous cost escalation of diesel, an alternate collector was developed utilizing the low-density polyethylene (LDPE) waste paving way for plastic waste utilization. The flotation efficacy of this new collector (Collector PE) derived from LDPE waste was compared with that of diesel in graphite flotation. The run-of mine graphite ore was initially size reduced for liberation of values from its associated impurities, followed by flotation. The mesh-of-grind, dosages of collector (diesel and PE) and frother (Methyl Isobutyl Carbinol, MIBC) were optimized for better process efficiency for increasing the surface hydrophobicity of graphite particles leading to better separation efficacy. The ore characterization by x-ray diffraction revealed that graphite was accompanied predominantly by quartz with minor fractions of pyrites and several other phyllosilicates such as kaolinite and muscovite. Exfoliated morphology of graphite with thick layers were observed from SEM images. Flotation reagents such as diesel, collector PE and MIBC were characterized by FTIR to analyze their functional groups that enhances the efficiency of the separation process. A graphite float (rougher concentrate) with 15.2% weight recovery and 17.7% ash content was obtained after 10 minutes of grinding (d80: 240.5µm) with 0.85kg/t of collector (diesel) and 0.07kg/t of frother (MIBC) dosages and on two-stage cleaning, a final concentrate with 12.66% weight recovery and 8.70% ash content was obtained. A graphite final concentrate with 13.04% weight recovery and 8.90 % ash was achieved with two-stage cleaning, when treated with 0.57 kg/t of collector PE and 0.07 kg/t of MIBC. These results indicate that the flotation efficiency of the collector PE derived from LDPE wastes is comparable with that of diesel and would be economical when used in large scale industrial graphite flotation

STUDY ON FLOTATION OF SILLIMANITE USING PLANT-BASED COLLECTOR

The coastal lines of India are rich in placer deposits of valuable heavy minerals such as ilmenite, garnet, rutile, zircon and sillimanite. The conducting and magnetic minerals are separated first, leaving behind the non-conducting and non-magnetic sillimanite along with quartz in the processing of heavies in beach sand. Sillimanite, an important mineral for refractory application is mainly recovered by flotation technique from its associated major gangue mineral, quartz by imparting selective surface hydrophobicity on sillimanite using a suitable collector. A placer sample after the removal of heavies from eastern coast of India was studied for beneficiation using froth flotation technique. Detailed characterization studies of the feed sample and the types of collectors used for this study have been carried out using XRD and FTIR analyses. Sillimanite feed sample assaying 55.4% sillimanite along with 33.9% quartz, 1.7% magnetics, 1.4% rutile, 2.4% zircon, 5.6% kynite was subjected to beneficiation using flotation technique for enriching the sillimanite content using oleic acid and a plant-based reagent SFA as collector. The effect of variation of input parameters such as pH, depressant and collectors were evaluated and flotation process optimization was carried out. Based on the results, it was found that flotation performance of the natural source based collector has better selectivity and improved recovery as compared to that of oleic acid as collector. Weight recovery of 67.8% with 85.1% sillimanite was obtained using the plant-based collector while a weight recovery of 55.5% with 84.9% sillimanite was obtained using oleic acid. The improved sillimanite recovery by using the plant-based collector than that of the conventional oleic acid would be more economical in industrial scale sillimanite recovery in beach sand processing industries

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

Background Underweight and obesity are associated with adverse health outcomes throughout the life course. We estimated the individual and combined prevalence of underweight or thinness and obesity, and their changes, from 1990 to 2022 for adults and school-aged children and adolescents in 200 countries and territories. Methods We used data from 3663 population-based studies with 222 million participants that measured height and weight in representative samples of the general population. We used a Bayesian hierarchical model to estimate trends in the prevalence of different BMI categories, separately for adults (age ≥20 years) and school-aged children and adolescents (age 5–19 years), from 1990 to 2022 for 200 countries and territories. For adults, we report the individual and combined prevalence of underweight (BMI <18·5 kg/m2) and obesity (BMI ≥30 kg/m2). For schoolaged children and adolescents, we report thinness (BMI <2 SD below the median of the WHO growth reference) and obesity (BMI >2 SD above the median). Findings From 1990 to 2022, the combined prevalence of underweight and obesity in adults decreased in 11 countries (6%) for women and 17 (9%) for men with a posterior probability of at least 0·80 that the observed changes were true decreases. The combined prevalence increased in 162 countries (81%) for women and 140 countries (70%) for men with a posterior probability of at least 0·80. In 2022, the combined prevalence of underweight and obesity was highest in island nations in the Caribbean and Polynesia and Micronesia, and countries in the Middle East and north Africa. Obesity prevalence was higher than underweight with posterior probability of at least 0·80 in 177 countries (89%) for women and 145 (73%) for men in 2022, whereas the converse was true in 16 countries (8%) for women, and 39 (20%) for men. From 1990 to 2022, the combined prevalence of thinness and obesity decreased among girls in five countries (3%) and among boys in 15 countries (8%) with a posterior probability of at least 0·80, and increased among girls in 140 countries (70%) and boys in 137 countries (69%) with a posterior probability of at least 0·80. The countries with highest combined prevalence of thinness and obesity in school-aged children and adolescents in 2022 were in Polynesia and Micronesia and the Caribbean for both sexes, and Chile and Qatar for boys. Combined prevalence was also high in some countries in south Asia, such as India and Pakistan, where thinness remained prevalent despite having declined. In 2022, obesity in school-aged children and adolescents was more prevalent than thinness with a posterior probability of at least 0·80 among girls in 133 countries (67%) and boys in 125 countries (63%), whereas the converse was true in 35 countries (18%) and 42 countries (21%), respectively. In almost all countries for both adults and school-aged children and adolescents, the increases in double burden were driven by increases in obesity, and decreases in double burden by declining underweight or thinness. Interpretation The combined burden of underweight and obesity has increased in most countries, driven by an increase in obesity, while underweight and thinness remain prevalent in south Asia and parts of Africa. A healthy nutrition transition that enhances access to nutritious foods is needed to address the remaining burden of underweight while curbing and reversing the increase in obesit

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic

Indigenization and development of column flotation technology at CSIR- NML Madras Centre

CSIR - National Metallurgical Laboratory Madras Centre made its mark at national level for indigenization and development of ‘Column Flotation technology’ for processing lean and fine-grained ores. The activities pertaining to it started in the middle of 1980s and have been continuing since then. Laboratory scale (74mm diameter) and Pilot plant scale (500mm diameter) flotation columns were designed, fabricated and field tested at various private and public sector mineral processing plants located across India. Development of column flotation technology achieved Technology Readiness Level - 9, implying that it is ready for successful deployment at commercial scale. The USP of the NML Madras Centre is providing One-stop solution for installing commercial scale flotation columns by collaborating and partnering with an EPC company M/s McNally Sayaji Engineering Limited (MSEL), Bengaluru and Reagents manufacturers and suppliers M/s Somu Organo-Chem Private Limited, Bengaluru and M/s Xanthate Technologies, Visakhapatnam. So far, 5 laboratory scale, 1 pilot scale and 6 commercial scale flotation columns were commissioned. Presently, two commercial scale flotation columns are under installation, one at Belatinda Coal Preparation Plant of M/s Tata Steel Limited (200 tpd) and another at Mineral Separation Plant (MSP) of M/s Kerala Mineral and Metals Limited (KMML), Chavara, Kerala for sillimanite flotation (150 tpd). Few case studies on beneficiation of iron ore, coal, limestone, barite and sillimanite using column flotation were discussed

Synthesis of 3-amino-2-methyl/ethyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-<i style="">d</i>] pyrimidin-4(3<i style="">H</i>)-one and its Schiff bases as possible antimicrobial and non-steroidal antiinflammatory agents <b style=""> </b>

2696-2703Ethyl 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate 1 has been converted into ethyl 2-(acetylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate 2a and ethyl 2-(propionylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate 2b. Compounds 2a and 2b on treatment with hydrazine hydrate give 3-amino-2-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimid-4(3H)-one 3a and 3-amino-2-ethyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimid-4(3H)-one 3b respectively. Compounds 3a and 3b have been treated with aromatic aldehydes to get Schiff bases 4a-l and 5a-l. The compounds have been characterized by spectral analysis and screened for antibacterial and antifungal activity. Eight compounds have also been screened for their antiinflammatory activity. A few of the compounds exhibit promising biological activity